NEW ISSUE OF GOLD
Explore the new issue of GOLD! From investigating how pop culture’s pharma bias can be recalibrated, to exploring blockchain’s ever-growing presence in the pharma landscape, the latest issue of GOLD considers the most prominent trends, triumphs and tribulations across the industry.
Preparing MSLs for
The MSL is becoming increasingly key in influencing pharma’s business outcomes. They must be empowered as much as sales reps to nail their HCP interactions.
Bolstering data ownership with blockchain
As the data ownership and trade debate reaches pharma and healthcare, how could blockchain networks benefit patients and companies alike?
How has India become a pharmaceutical powerhouse in vaccines and generics, while also struggling with access to medicine issues?
A pandemic response
in 100 days
This infographic tracks CEPIs mission to create a vaccine in only 100 days.
WE TALK TO...
International CEO, WPP Health Practice
We sit down with Claire Gillis, who discusses how the communications role can transform patient outcomes.
Global Head Biopharmaceuticals, Sandoz
Pierre Bourdage provides insight into the state and future of the biosimilars market and discusses how to adapt to ‘the new normal'.
Vice President Hematology EMEA, Commercial Strategy Lead, Janssen
Mircea Cubillos discusses progression in oncology during COVID-19, and cultivating healthy habits during lockdown.